Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

Completed · Phase 1 · Has a placebo group

Conditions studied: Osteoarthritis of the Knee

In brief

The objective of the study is to determine the safety and tolerability of two different formulations of BMP-7 for the treatment of osteoarthritis of the knee.

Key facts

Study ID
NCT01133613
Run by
Stryker Biotech
People needed
51
Starts
2010-05-01
Expected to finish
2011-10-01
Last updated by the study team
2012-02-01

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.